Comparison of two regimens for the treatment of elderly patients with acute lymphoblastic leukaemia (ALL)

REFERENCES

• Copelan EA, McGuire EA. The biology of acute lympho-blastic leukemia in adults. Blood 1995;85:1151.
   Google Scholar
• Faderl S, Kantarjian HM, Talpaz M, Estrov Z. Clinical significance of cytogenetic abnormalities in ault acute lymphoblastic leukaemia. Blood 1998;91:3995— 4019.
   Google Scholar
• Damiani D, Michelutti A, Michieli M, Masolini P, Stocchi R, Geromin A, Ermacora A, Russo D, Fanin R, Baccarani M. P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lympho-blastic leulemia. British Journal of Haematology 2002;116: 519–527.
   Google Scholar
• Hernandez JA, Land KJ, McKenna RW. Leukemias, myeloma, and other lymphoreticular neoplasms. Cancer 1995;75:381 —394.
   Google Scholar
• Offidani M, Corvatta L, Centurioni R, Leoni F, Malerba L, Mele A, Marconi M, Scortichini A, Masia MC, Leoni P. High-dose daunorubicin as liposomal compound (Daunox-ome) in elderly patients with acute lymphoblastic leukemia. The Hematology Journal 2003;4:47 —53.
   Google Scholar
• Annino L, Vegna ML, Camera A, Specchia G, Visani G, Fioritoni G, Ferrara F, Peta A, Ciolli S, Deplano W, et al. Treatment of adult acute lymphoblastic leucemia (ALL): Long-term follow-up of the GIMEMA ALL 0288 rando-mized study. Blood 2002;99:863— 871.
   Google Scholar
• Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. The French-American-British (FAB) Cooperative Group. The morphological classification of acute lymphoblastic leukemia: concordance among observers and clinical correlation. British Journal of Haematology 1981;47: 553— 561.
   Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. Journal of American Statistic Assi-ciation 1958;53:457 —481.
   Google Scholar
• Delannoy A, Ferrant A, Bosly A, Chatelain C, Doyen C, Martiat P, Michaux JL, Sokal G. Acute lymphoblastic leukemia in the elderly. European Journal of Haematology 1990;45:90— 93.
   Google Scholar
• Taylor PRA, Reid MM, Bown N, Hamilton PJ, Proctor SJ. Acute lymphoblastic leukemia in patients aged 60 years and over: a population-based study of incidence and outcome. Blood 1992;80: 1813–1817.
   Google Scholar
• Spath-Schwalbe E, Heil G, Heimpel H. Acute lymphoblastic leukemia in patients over 59 years of age. Experience in a single center over a 10-year period. Annals of Hematology 1994;69: 291 —296.
   Google Scholar
• Ferrari A, Annino L, Crescenzi S, Romani C, Mandelli F. Acute lymphoblastic leukemia in the elderly: results of two different treatment approaches in 49 patients during a 25-year period. Leukemia 1995;9: 1643–1647.
   Google Scholar
• Pagano L, Mele L, Casorelli I, Fianchi L, Di Febo A, Leone G. Acute lymphoblastic leukemia in the elderly. A twelve-year retrospective, single center study. Haematologica 2000; 85:1327–1329.
   Google Scholar
• Thomas X, Olteanu N, Charm in C, Lheritier V, Magaud JP, Fiere D. Acute lymphoblastic leukemia in the elderly: the Eduard Herriot Hospital experience. American Journal of Haematology 2001;67:73— 83.
   Google Scholar
• Robak T, Szmigielska-Kaplon A, Wrzesien-Kus A, Wierz-bowska A, Skotnicki AB, Piatkowska-Jakubas B, Kuliczkowski K, Masur G, Zdunczyk A, Stella-Holowiecka B, et al. Acute lymphoblastic leukemia in elderly: the Polish Adult Leukemia Group (PALG) experience. Annals of Hematology 2004;83:225 —231.
   Google Scholar
• Ellison RR, Mick R, Cuttner J, Schiffer CA, Silver RT, Henderson ES, Woliver T, Royston I, Davey FR, Glichsman AS, et al. The effect of post-induction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomised clinical trial by Cancer and Leukemia Group B. Journal of Clinical Oncology 1991;9:2002–2015.
   Google Scholar
• Kantarjian HM, O'Brian S, Smith T, Estey EH, Beran M, Preti A, Pierce S, Keating MJ. Acute lymphocytic leukaemia in the elderly: characteristics and outcome with the vincris-tine-adriamycin-dexamethasone (VAD) regimen. British Journal of Haematology 1994;88:94 —100.
   Google Scholar
• Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Sculman P, Duggan D, Davey FR, Sobol RE, Frankel SR, et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 8811. Blood 1995;85: 2025 — 2037.
   Google Scholar
• Kantarjian HM, O'Brian S, Smith TL, Cortes J, Giles FJ, Beran M, Pierce S, Huh Y, Andreeff M, Koller C, et al. Results of treatment with Hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. Journal of Clinical Oncology 2000;18:547–561.
   Google Scholar
• Hallbook H, Simonsson B, Ahlgren T, Bjorkholm M, Cameskog J, Grimfors G, Hast R, Karlsson K, Kimby E, Lerner R, et al. High-dose ctarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia. British Journal of Haematology 2002;118:748–754.
   Google Scholar
• Bassan R, Di Bona E, Lerede T, Pogliani E, Rossi G, D'Emilio A, Buelli M, Rambaldi A, Viero P, Rodeghiero F, Barbui T. Age-adapted moderate-dose induction and flexible outpatient postremission therapy for elderly patients with acute lymphoblastic leukemia. Leukemia and Lymphoma 1996;22:295 — 301.
   Google Scholar
• Delannoy A, Sebban C, Cony-Makhoul P, Cazin B, Cordonnier C, Bouabdallah R, Cahn JY, Dreyfus F, Sadoun A, Vernant JP, et al. Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemother-apy. A multicentric prospective study in forty patients. Leukemia 1997;11:1429— 1434.
   Google Scholar
• Mandelli F, Annino L, Vegna ML, Ferrari A, Di Raimondo F, Invemizzi R, et al. Treatment of acute lymphoblastic leukemia in the elderly: result of the GIMEMA ALL 0288 60 years trial. In: Acute Leukemias VI. Prognostic factors and treatment strategies, edited by Buchner et al, 1997. pp 688–694.
   Google Scholar
• Offidani M, Corvatta L, Malerba L, Marconi M, Leoni P. Infectious complications in adult acute lymphoblastic leuce-mia (ALL): experience at one single center. Leukemia and Lymphoma 2004;45:1617 — 1621.
   Google Scholar
• Russo D, Piccaluga PP, Michieli M, Michelutti T, Visani G, Gugliotta L, Bonini A, Pierri I, Gobbi M, Tiribelli M, et al. Liposomal daunorubicin (Daunoxome) for treatment of poor-risk acute leukemia. Annals of Hematology 2002;81: 462 — 466.
   Google Scholar
• Thomas DA, Faderl S, Cortes J, O'Brian S, Giles FJ, Komblau SM, Garcia-Manero G, Keating MJ, Andreef M, Jeha S, et al. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia with Hyper-CVAD and im-atinib mesylate. Blood 2004;103:4396— 4407.
   Google Scholar
• Martino R, Giralt S, Caballero MD, Mackinnon S, Corradini P, Fernandez-Aviles F, San Miguel J, Sierra J. Allogeneic hematopoietic stem cell transplantation with reduced-inten-sity conditioning in acute lymphoblastic leukemia: a feasibility study. Haematologica 2003;88:555 —560.
   Google Scholar